Skip to main content
Top
Published in: Journal of Gastroenterology 7/2016

01-07-2016 | Editorial

Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

Authors: Atsushi Tanaka, Hajime Takikawa, Satoshi Mochida, Kazuhiko Koike, Hiroto Miwa, Toru Shimosegawa

Published in: Journal of Gastroenterology | Issue 7/2016

Login to get access

Excerpt

Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease, frequently developing in middle-aged women [1]. In patients with PBC, small bile ducts in the liver are believed to be damaged via autoimmune reactions [2]. Patients were diagnosed as having PBC when 2 or more among the following 3 features are observed; elevated cholestatic enzymes, presence of anti-mitochondrial autoantibodies (AMA) and histological findings as chronic non-suppurative destructive cholangitis (CNSDC) in particular [3]. When the disease entity of PBC was established more than 50 years ago [4], advanced liver diseases showing histological findings of cirrhosis were found in the most of patients with PBC. Consequently, a nomenclature for primary biliary “cirrhosis” was reasonably accepted by all hepatologists and gastroenterologists world-widely. …
Literature
1.
go back to reference Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015; 17; 386(10003):1565-75. Carey EJ, Ali AH, Lindor KD. Primary biliary cirrhosis. Lancet. 2015; 17; 386(10003):1565-75.
2.
go back to reference Gershwin ME, Ansari A, Mackay I, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210–25.CrossRefPubMed Gershwin ME, Ansari A, Mackay I, et al. Primary biliary cirrhosis: an orchestrated immune response against epithelial cells. Immunol Rev. 2000;174:210–25.CrossRefPubMed
3.
go back to reference Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: the intractable hepatobiliary disease study group supported by the Ministry of health, labour and welfare of Japan. Hepatol Res. 2014;44 (Suppl S1):71–90. Working Subgroup (English version) for Clinical Practice Guidelines for Primary Biliary Cirrhosis. Guidelines for the management of primary biliary cirrhosis: the intractable hepatobiliary disease study group supported by the Ministry of health, labour and welfare of Japan. Hepatol Res. 2014;44 (Suppl S1):71–90.
5.
go back to reference Gershwin ME, Mackay I, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525–31.PubMed Gershwin ME, Mackay I, Sturgess A, et al. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987;138:3525–31.PubMed
6.
go back to reference Abbas G, Lindor KD. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Expert Opin Pharmacother. 2010;11:387–92.CrossRefPubMed Abbas G, Lindor KD. Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid. Expert Opin Pharmacother. 2010;11:387–92.CrossRefPubMed
7.
go back to reference Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. J Hepatol. 2015;63:1285–7.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. J Hepatol. 2015;63:1285–7.CrossRefPubMed
8.
go back to reference Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. Hepatology. 2015;62:1620–2.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: From ‘cirrhosis’ to ‘cholangitis’. Hepatology. 2015;62:1620–2.CrossRefPubMed
9.
go back to reference Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Gastroenterology. 2015;149:1627–9.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Gastroenterology. 2015;149:1627–9.CrossRefPubMed
10.
go back to reference Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Gut. 2015;64:1671–2.CrossRefPubMed Beuers U, Gershwin ME, Gish RG, et al. Changing nomenclature for PBC: from ‘cirrhosis’ to ‘cholangitis’. Gut. 2015;64:1671–2.CrossRefPubMed
11.
go back to reference Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol. 2015;110:1536–8.CrossRefPubMedPubMedCentral Beuers U, Gershwin ME, Gish RG, et al. Changing Nomenclature for PBC: From ‘Cirrhosis’ to ‘Cholangitis’. Am J Gastroenterol. 2015;110:1536–8.CrossRefPubMedPubMedCentral
Metadata
Title
Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”
Authors
Atsushi Tanaka
Hajime Takikawa
Satoshi Mochida
Kazuhiko Koike
Hiroto Miwa
Toru Shimosegawa
Publication date
01-07-2016
Publisher
Springer Japan
Published in
Journal of Gastroenterology / Issue 7/2016
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/s00535-016-1223-z

Other articles of this Issue 7/2016

Journal of Gastroenterology 7/2016 Go to the issue